Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
Children born preterm have an increased risk of severe morbidity, e.g. cerebral palsy (CP), compared to children born at term. CP cannot be treated, which is why a prophylactic approach is essential, as argued in this review. Six randomised controlled trials (RCTs) have provided data on MgSO4 treatment as CP neuroprotection in preterm birth, including a new RCT from Denmark. Recently, an updated meta-analysis with trial sequential analysis detected a significant neuroprotective effect of MgSO4 treatment in preterm birth. There is now sufficient evidence, that MgSO4 treatment should be used as neuroprotection in preterm birth.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 182 |
Udgave nummer | 47 |
ISSN | 0041-5782 |
Status | Udgivet - 16 nov. 2020 |
ID: 61730534